Saturday, December 20, 2025

Latest

Tilray Brands Proposes Reverse Split Of Up To 20-To-1 To Regain Nasdaq Compliance

Tilray Brands (TSX: TLRY) is seeking shareholder approval to conduct a reverse stock split in an effort to regain compliance with Nasdaq minimum listing standards.

The company is proposing a reverse stock split that would occur at a ratio ranging from 10-to-1 to 20-to-1, with the board of directors to ultimately select where within this range the split would fall once shareholder approval is granted. A special meeting of shareholders is planned for June 10, 2025 to vote on the matter.

“The Reverse Stock Split will better align Tilray’s number of shares outstanding with companies of our size and scope. A higher price per share would ensure compliance with Nasdaq’s continued listing requirements and places Tilray in a position to continue executing on our strategic plans,” commented Irwin Simon, CEO of Tilray.

The company has also claimed that conducting the reverse split would decrease the cost structure of Tilray by up to $1.0 million on an annual run rate basis, however it is unclear how this would be achieved.

Tilray at the present time has an estimated 937.66 million shares outstanding.

Tilray Brands last traded at $0.66 on the TSX.


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Soma Gold: Q3 Earnings Impacted By Labour Strike

Thesis Gold: The Multi-Billion Dollar Lawyers-Ranch PFS

Why Canada Has So Few Projects That Can Be Built Before 2030 | Dan Wilton – First Mining

Recommended

Northern Superior Shareholders Set To Receive Shares Of ONGold Resources Friday

Goliath Resources Sees Rob McEwen Increase Ownership Interest

Related News

Democrats Take Aim At “Big Cannabis” In Proposed CAOC Legislation

It appears that the federal legalization of cannabis in the United States might not be...

Tuesday, September 7, 2021, 05:33:00 PM

Tilray Selected To Supply Medical Cannabis For French Experimental Program

Tilray Inc (NASDAQ: TLRY) has expanded its international operations to now include France. The company...

Tuesday, January 26, 2021, 07:55:19 AM

Tilray Looks To Buy US$211 Million In Hexo Debt, Enter Strategic Alliance

In a sign that the Canadian cannabis operators continue to struggle, especially in terms of...

Thursday, March 3, 2022, 07:37:18 AM

Aphria, Tilray Announce $5 Billion Merger Justified By Topline Revenues

Well it appears the rumours have finally come to fruition when it comes to Aphria...

Wednesday, December 16, 2020, 07:39:40 AM

Tilray: Cantor Slashes Price Target To $7.40 Ahead Of Earnings

Tilray (TSX: TLRY) is expected to report its second fiscal quarter 2022 results on January...

Friday, January 7, 2022, 03:58:00 PM